Zobrazeno 1 - 10
of 70
pro vyhledávání: '"Ken-ichi Fujimoto"'
Publikováno v:
Neurology Research International, Vol 2013 (2013)
Previous studies addressing preoperative steroid treatment have revealed that control of myasthenia gravis (MG) with steroids prior to surgery appeared to stabilize postoperative status. The purpose of our study was to clarify the clinical benefits o
Externí odkaz:
https://doaj.org/article/23dffaf2ef9248758779645ac6f91e3e
Autor:
Ken-Ichi, Fujimoto
Publikováno v:
Brain and nerve = Shinkei kenkyu no shinpo. 74(5)
The most important factor in the treatment of functional movement disorders is the initial discussion between the doctor and the patient, wherein the doctor must inform the patient regarding their diagnosis and obtain their consent. To obtain consent
Autor:
Manabu Funayama, Taku Hatano, Mitsuaki Oki, Arisa Hayashida, Junko Fujitake, Hiroyo Yoshino, Ken-Ichi Fujimoto, Kaoru Mogushi, Yoshiki Sekijima, Yasuro Shibagaki, Aya Ikeda, Kenya Nishioka, Takekazu Ohi, Nobutaka Hattori, Daigo Miyazaki, Yoshikazu Ugawa, Yutaka Machida, Yutaka Oji, Yuanzhe Li, Hirofumi Kusaka, Hiroshi Iwanaga, Genko Oyama, Yasushi Shimo, Ai Hosaka
Publikováno v:
Journal of Neurology. 265:1860-1870
Guanosine triphosphate cyclohydrolase I (GCH1) mutations are associated with increased risk for dopa-responsive dystonia (DRD) and Parkinson’s disease (PD). Herein, we investigated the frequency of GCH1 mutations and clinical symptoms in patients w
Autor:
Keiya Ozawa, Ken-ichi Fujimoto, Yuko Katakai, Mika Ito, Naomi Takino, Shin-ichi Muramatsu, Kunihiko Ikeguchi, Fumiko Ono, Yoshihide Sehara
Publikováno v:
Human Gene Therapy Clinical Development. 28:74-79
Restoring dopamine production in the putamen through gene therapy is a straightforward strategy for ameliorating motor symptoms for Parkinson's disease (PD). In a 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) toxicity-based primate model of PD,
Autor:
Kazushi Takahashi, Koichi Hirata, Yasuyuki Okuma, Akira Kurita, Ken-ichi Fujimoto, Toshimasa Yamamoto, Ken Ikeda, Toshiya Fukui, Fumihito Yoshii, Satoshi Kamei, Shigeru Nogawa, Hisayoshi Oka, Kaoru Yamazaki, Yoshihito Ando, Nobutaka Hattori, Hiroya Utsumi
Publikováno v:
Movement disorders clinical practice. 6(3)
Background Postural abnormalities in Parkinson's disease (PD) patients and unimpaired elderly are not well differentiated. Factors related to postural abnormality associated with PD are controversial. Objective We assessed differences in postural cha
Publikováno v:
Neurology and Clinical Neuroscience. 3:119-126
Background Previously, we identified a brain-type creatine kinase antibody to be associated with paraneoplastic cerebellar degeneration using a proteomic approach. Immunohistochemistry showed that this antibody reacted with both mouse cerebellar neur
Publikováno v:
Brain and nerve = Shinkei kenkyu no shinpo. 68(9)
A large-scale patient survey was conducted in 2013 and results compared with those of a similar scale survey conducted in 2008 to clarify the current status of drug therapy and patients' understanding of Parkinson disease (PD) and therapy. A total of
Autor:
Y. Katakai, K. Ikeguchi, K. Ozawa, Ken-ichi Fujimoto, F. Ono, M. Ito, Y. Sehara, Shin-ichi Muramatsu, N. Takino
Publikováno v:
Journal of the Neurological Sciences. 381:139-140
Autor:
Ken-ichi Fujimoto
Publikováno v:
Japanese Journal of Neurosurgery. 20:87-92
Publikováno v:
Gene Therapy and Regulation. :57-65
The cardinal motor symptoms of Parkinson's disease (PD) are associated with the profound depletion of dopamine in the striatum. The replacement of dopamine is the most straightforward strategy to improve motor performance in PD. Researchers have been